Financhill
Back

Arcutis Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
39

ARQT
Arcutis Biotherapeutics

Last Price:
10.25
Seasonality Move:
47.83%
Sell
40

NBY
NovaBay Pharmaceuticals

Last Price:
0.80
Seasonality Move:
-7.72%
Sell
39
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.84. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.84
    The current trend is moderately bullish and ARQT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 70.45 Buy
Chaikin Money Flow: -549607 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.47 - 10.03) Buy
Bollinger Bands (100): (8.89 - 10.43) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 55.22 Buy
Chaikin Money Flow: 6757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.72) Buy
Bollinger Bands (100): (0.29 - 1.67) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.62 Buy
20-day SMA: 9.12 Buy
50-day SMA: 9.7 Buy
200-day SMA: 9.31 Buy
8-day EMA: 9.93 Buy
20-day EMA: 9.48 Buy
50-day EMA: 9.49 Buy
200-day EMA: 9.09 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.66 Buy
50-day SMA: 0.62 Buy
200-day SMA: 2.54 Sell
8-day EMA: 0.7 Buy
20-day EMA: 0.68 Buy
50-day EMA: 0.74 Sell
200-day EMA: 6.02 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):